<DOC>
	<DOCNO>NCT01553617</DOCNO>
	<brief_summary>The study compare efficacy safety VolulyteTM human albumin elective open-heart surgery adult patient .</brief_summary>
	<brief_title>VolulyteTM Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>male female adult patient undergoing primary elective cardiac surgery apply extracorporeal circulation sign write informed consent know contraindication schedule medication preoperative acute normovolaemic haemodilution preoperative autologous blood donation plan systemic hypothermia ( body temperature &lt; 30°C ) expect time ECC ≥ 2 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>